In the News

April 17, 2024

SaponiQx and InvivoGen Announce Agreement for SaponiQx to Supply Cultured Plant Cell QS-21 Adjuvant

Read More

February 15, 2024

Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design

Read More

October 10, 2023

SaponiQx Advances Vaccine Development With the Availability of cGMP QS-21 From Its Proprietary Cultured Plant Cell Source

Read More

August 9, 2023

SaponiQx Announces Breakthrough in Scaling Up of STIMULON™ Cultured Plant Cell Adjuvant

Read More

April 28, 2023

Watch SaponiQx Presentation at Ginko Ferment Conference, 2023

Watch Video

April 27, 2023

Perspectives on World Immunization Day 2023

Read More

March 1, 2023

US FDA Advisory Committee votes to support effectiveness and safety of GSK’s respiratory syncytial virus older adult vaccine candidate

Read More

February 1, 2023

SaponiQx joins Medical CBRN Defense Consortium

Read More

September 10, 2021

New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks

Read More

SaponiQx
3 Forbes Road
Lexington, MA 02421-7305
T: 781.674.4445

Linkedin